Background illustration for clinical trials search

Paid Clinical Trials Murfreesboro

Discover 1,249 paid clinical trials in Murfreesboro, Tennessee. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors

for
Advanced Solid Tumor
Location: Nashville TN, Germantown TN, Jacksonville FL,
Sponsor: Exelixis

Sex: All

Age: 18+

Code: NCT05932862

Phase1, Recruiting

A Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Clinical Activity of Mocertatug Rezetecan for Injection in Participants With Advanced Solid Tumors (BEHOLD-1)

for
Solid Tumors, Neoplasms
Location: Nashville TN, Birmingham AL, Detroit MI,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18+

Code: NCT06431594

Phase1, Recruiting

First-in-human Study of DB-1419 for Advanced/Metastatic Solid Tumors

for
Solid Tumor, Adult
Location: Nashville TN, Huntersville NC, Chicago IL,
Sponsor: DualityBio Inc.

Sex: All

Age: 18+

Code: NCT06554795

Phase1, Phase2, Recruiting

A Study to Evaluate the Efficacy and Safety of Belantamab Mafodotin in Combination With Standard of Care in Participants With Relapsed-Refractory Multiple Myeloma (RRMM)

for
Multiple Myeloma
Location: Nashville TN, Macon GA, Bridgeton MO, Springfield MO,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18+

Code: NCT07227311

Phase2, Recruiting

A Study to Investigate the Safety and Preliminary Efficacy of GSK5460025 Alone or in Combination With Other Anti-cancer Agents in Participants With Solid Tumors

for
Neoplasms, Colorectal, Neoplasms
Location: Nashville TN, Canton OH, Detroit MI, Hamilton, Toronto,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18+

Code: NCT07213609

Phase1, Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

for
Renal Cell Carcinoma (RCC),
Location: Nashville TN, Louisville KY, Indianapolis IN, Durham NC,
Sponsor: Exelixis

Sex: All

Age: 18+

Code: NCT05176483

Phase1, Recruiting

Relacorilant With Nab-Paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic Adenocarcinoma

for
Adenocarcinoma, Carcinoma, Pancreatic Ductal
Location: Nashville TN, Atlanta GA, Cincinnati OH, Goshen IN,
Sponsor: Corcept Therapeutics

Sex: All

Age: 18+

Code: NCT07259317

Phase2, Recruiting

A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors

for
HNSCC, ESCC, Esophageal Adenocarcinoma, Gastric Adenocarcinoma,
Location: Nashville TN, St Louis MO, Maumee OH, Charleston SC,
Sponsor: Normunity AccelCo, Inc.

Sex: All

Age: 18+

Code: NCT07182149

Phase1, Recruiting

A Dose-masked Study of Intravitreal EYE103 in Participants With NVAMD or Macular Edema Following BRVO

for
Neovascular Age-Related Macular Degeneration (NVAMD),
Location: Nashville TN, Knoxville TN, Germantown TN, Asheville NC,
Sponsor: EyeBiotech Ltd.

Sex: All

Age: 18+

Code: NCT07205887

Phase2, Recruiting

Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors

for
Advanced Solid Tumor, Metastatic Solid Tumor, Prostate Cancer,
Location: Nashville TN, St Louis MO, Lake Mary FL,
Sponsor: MOMA Therapeutics

Sex: All

Age: 18+

Code: NCT06545942

Phase1, Recruiting

A Study of PHN-012 in Patients With Advanced Solid Tumors

for
Colon Cancer, Pancreatic Cancer, Lung Cancer (NSCLC),
Location: Nashville TN, St Louis MO, Durham NC, Fairfax VA,
Sponsor: Pheon Therapeutics

Sex: All

Age: 18+

Code: NCT07127874

Phase1, Recruiting

A Study to Investigate the Safety and Efficacy of Belantamab for the Treatment of Multiple Myeloma When Used as Monotherapy and in Combination Treatments

for
Multiple Myeloma
Location: Nashville TN, Chattanooga TN, Chapel Hill NC, Canton OH,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18+

Code: NCT05714839

Phase1, Phase2, Recruiting

A Study of GSK5458514 Administered Alone or In Combination With Other Anti-Cancer Agents in Participants With Prostate Cancer

for
Neoplasms, Prostate
Location: Nashville TN, Rochester MN, East Brunswick NJ,
Sponsor: GlaxoSmithKline

Sex: Male

Age: 18+

Code: NCT06990880

Phase1, Phase2, Recruiting

A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma

for
Neoplasms, Head and Neck
Location: Nashville TN, Chattanooga TN, Lexington KY, Atlanta GA,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18+

Code: NCT06256588

Phase3, Recruiting

A Study of XB628 Alone and in Combination With Zanzalintinib in Participants With Recurrent Advanced or Metastatic Solid Tumors

for
Solid Tumor, Advanced Solid Tumor, Metastatic Solid Tumor,
Location: Nashville TN, Hickory NC, St Louis MO, Tampa FL,
Sponsor: Exelixis

Sex: All

Age: 18+

Code: NCT06952010

Phase1, Recruiting

Evaluate REC-4881 in Participants With Familial Adenomatous Polyposis (FAP)

for
Familial Adenomatous Polyposis
Location: Nashville TN, St Louis MO, Dallas TX, Philadelphia PA,
Sponsor: Recursion Pharmaceuticals Inc.

Sex: All

Age: 18+

Code: NCT05552755

Phase1, Phase2, Recruiting

A Study of AAV2-GDNF in Adults With Moderate Parkinson's Disease (REGENERATE-PD)

for
Parkinson Disease
Location: Nashville TN, Chapel Hill NC, Durham NC, Chicago IL,
Sponsor: AskBio Inc

Sex: All

Age: 45 - 70+

Code: NCT06285643

Phase2, Recruiting

A Study of AP-CD/LD in Fluctuating Parkinson's Disease Patients Who Completed IN 11 004

for
Parkinson's Disease
Location: Nashville TN, Birmingham AL, Chicago IL,
Sponsor: Intec Pharma Ltd.

Sex: All

Age: 30 - 70+

Code: NCT02615873

Phase3, Recruiting

MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors

for
Pancreatic Ductal Adenocarcinoma, Non-small Cell Lung Cancer,
Location: Nashville TN, Denver CO, Atlanta GA, Cincinnati OH,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT06586515

Phase1, Recruiting

A Long Term, Post-marketing Study of Immune Response in Patients Receiving Palynziq Treatment for PKU (PALisade)

for
Phenylketonuria (PKU)
Location: Nashville TN, Atlanta GA, Indianapolis IN, Chicago IL,
Sponsor: BioMarin Pharmaceutical

Sex: All

Age: 0+

Code: NCT06305234

Recruiting